// November 27, 2023
Q&A: Building a More Resilient Medicines Supply Chain
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
Patient access to cancer drugs can mean the difference between life and death.
The development of generic versions of innovator medicines is a global public health need.
Innovation and standardization across borders are essential to facilitate manufacturing solutions